Understanding early autism evaluations and why it matters whether a developmental pediatrician or a clinical psychologist ...

The past 12 months mark a milestone year for the discipline of sports and exercise cardiology.We have seen the publication of two major guideline documents for athletes: the 2025 American Heart Associ ...

In a clinical report issued by the American Academy of Pediatrics and published online June 23 in Pediatrics, guidance is ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Panelists discuss how integrating subcutaneous (SubQ) therapies into oncology practice involves thorough economic evaluation, ...

Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), today ...

Updated 1:40 p.m. Thursday. For the first time in over 50 years, emergency room doctors will have a new framework to assess people with head injuries from car or bike crashes, falls and assaults..

Kymera Therapeutics announced new clinical trials for KT-621, targeting atopic dermatitis and asthma, ... KT-621, the first STAT6 directed medicine to enter clinical evaluation, ...

SAN DIEGO--(BUSINESS WIRE)--Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell ...

Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), today ...